A

APCOR R&M (Private limited company)

BE 0600.952.909 Active ●Technologiepark-Zwijnaarde 82, 9052 Gand

APCOR R&M is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0600.952.909. It was founded on 10-03-2015. Its registered office is in Ghent. Its main activity is: Manufacture of basic pharmaceutical products and pharmaceutical preparations. Its annual accounts for 2025 report equity of € -359 177 and a loss of € 14 763. Addrly gives it a financial health grade of E, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for 2 of its last 4 financial years.

Information last updated on 10-10-2026.

Company information

Status
Active
Enterprise number
BE 0600.952.909
VAT registered
Yes
Founded
10-03-2015
Latest accounts
2025
Employees
-
Region
Flanders
Establishments
1
Filing record
On time 2 of 4 years
Peppol e-invoicing
Registered
Registered office
Technologiepark-Zwijnaarde 82, 9052 Gand
Main activity
Manufacture of basic pharmaceutical products and pharmaceutical preparations
NACE activities
21100 Fabrication de produits pharmaceutiques de base
46851 Commerce de gros de produits chimiques à usage industriel
72109 Recherche-développement en autres sciences physiques et naturelles
74999 Autres activités des professions libérales et autres activités scientifiques et techniques, nca

Key figures of APCOR R&M

2025202420232022
Profit / loss
iWhat the period earned after taxes. A negative amount is a loss.
€ -14 763+51 %€ -30 300-4 %€ -29 183+41 %€ -49 639
Equity
iWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company.
€ -359 177-4 %€ -344 414-10 %€ -314 114-10 %€ -284 932
Total assets
iEverything the company owns. Equal to total equity and liabilities, which says how it is financed.
€ 5 677-25 %€ 7 525-68 %€ 23 207-40 %€ 38 962
Gross margin
iSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else.
€ -11 408+10 %€ -12 717-3 %€ -12 391+9 %€ -13 625
Employees (FTE)
iAverage number of workers over the period, in full-time equivalents.
----

Financial estimate

Financial health grade E, on a scale from A (safest) to E (most at risk)
Health barometer
The failure probability and the indicators behind this grade are visible with a free account.
Create a free account
Illustrative preview
Detected events
Appointments, capital, registered office, proceedings, extracted from the official acts.
Create a free account
Illustrative preview
Directors & mandates
2 mandates on record in the annual accounts.
Create a free account

Similar companies

Other companies in the same activity in Ghent.

CompanyTown
RNA Pioneering 9052 Gent
Eurofins Amatsigroup 9052 Gent
Taikun Pharmaceutical Technology 9052 Gent
272BIO 9052 Gent
AVROXA 9052 Gent
ILiAD Biotechnologies 9052 Gent
AnimAb 9052 Gent
Ziphius 9052 Gent
Looking for more information about APCOR R&M?
The free plan gives you 20 complete company dossiers every month, no card required: health barometer, directors, company links and detected events.
Create a free account

Frequently asked questions

Is APCOR R&M still active? Yes. The Crossroads Bank for Enterprises lists APCOR R&M as active.

What is the VAT number of APCOR R&M? The VAT number of APCOR R&M is BE 0600.952.909.

When was APCOR R&M founded? APCOR R&M was founded on 10-03-2015.

What is the address of APCOR R&M? The current registered office of APCOR R&M is Technologiepark-Zwijnaarde 82, 9052 Gand.

When did APCOR R&M last file annual accounts? The latest annual accounts of APCOR R&M were filed on 31-08-2026.

Does APCOR R&M file its annual accounts on time? APCOR R&M filed its annual accounts within the legal deadline for 2 of its last 4 financial years. Late: 2022, 2025.

Is APCOR R&M financially healthy? Addrly gives APCOR R&M a financial health grade of E, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.

Is APCOR R&M profitable? The annual accounts of APCOR R&M for 2025 show a loss of € 14 763.

What is the equity of APCOR R&M? The equity of APCOR R&M was € -359 177 at the close of the 2025 financial year.

Who are the directors of APCOR R&M? The annual accounts of APCOR R&M record 2 mandates. The names, roles and dates are visible with a free account.

Can APCOR R&M receive Peppol e-invoices? Yes. APCOR R&M is registered on the Peppol network and can receive structured electronic invoices.

What does APCOR R&M do? The main activity of APCOR R&M is: Manufacture of basic pharmaceutical products and pharmaceutical preparations.

Sources

How Addrly builds and refreshes this data